References
1.Marco R, Stefania F, Francesco R. Heterogeneity of terminology and
clinical definitions in adult idiopathic thrombocytopenic purpura: a
critical appraisal from a systematic review of the literature.
Haematologica. 2008;93:98-103.
2.Neunert C, Noroozi N, Norman G, et al. Severe bleeding events in
adults and children with primary immune thrombocytopenia: a systematic
review. Journal of thrombosis and haemostasis : JTH. 2015;13:457-64.
3.Cooper N, Bussel J. The pathogenesis of immune thrombocytopaenic
purpura. British journal of haematology. 2006;133:364-74.
4.Zong X, Gu Y, Yu H, Li Z, Wang Y. Thrombocytopenia Is Associated with
COVID-19 Severity and Outcome: An Updated Meta-Analysis of 5637 Patients
with Multiple Outcomes. Lab Med. 2021;52:10-5.
5.Kewan T, Gunaratne TN, Mushtaq K, Alayan D, Daw H, Haddad A. Outcomes
and management of immune thrombocytopenia secondary to COVID-19:
Cleveland clinic experience. Transfusion.n/a.
6.Bhattacharjee S, Banerjee M. Immune Thrombocytopenia Secondary to
COVID-19: a Systematic Review. SN Compr Clin Med. 2020:1-11.
7.de la Cruz-Benito B, Rivas-Pollmar MI, Álvarez Román MT, et al.
Paradoxical effect of SARS-CoV-2 infection in patients with immune
thrombocytopenia. British journal of haematology. 2021;192:973-7.
8.Biyani G, Azad SM, Guha S, Kapoor R, De H. Recurrent immune
thrombocytopenic purpura with excellent prognosis. 2017. 2017;5:3.
9.Braga JAP, Loggetto SR, Hoepers ATdC, Bernardo WM, Medeiros L,
Veríssimo MPdA. Guidelines on the diagnosis of primary immune
thrombocytopenia in children and adolescents: Associação Brasileira de
Hematologia, Hemoterapia e Terapia Celular Guidelines Project:
Associação Médica Brasileira - 2012. Rev Bras Hematol Hemoter.
2013;35:358-65.
10.Rodeghiero F, Michel M, Gernsheimer T, et al. Standardization of
bleeding assessment in immune thrombocytopenia: report from the
International Working Group. Blood. 2013;121:2596-606.
11.Pavord S, Thachil J, Hunt BJ, et al. Practical guidance for the
management of adults with immune thrombocytopenia during the COVID-19
pandemic. British journal of haematology. 2020;189:1038-43.